Other forms of blastomycosis
ICD-10 B40.8 is a billable code used to indicate a diagnosis of other forms of blastomycosis.
Blastomycosis is a systemic fungal infection caused by the dimorphic fungus Blastomyces dermatitidis, primarily affecting the lungs but can disseminate to other organs. Other forms of blastomycosis (B40.8) refer to atypical presentations of the disease that do not fit the classic pulmonary or cutaneous forms. These may include disseminated blastomycosis affecting the bones, joints, or central nervous system. Patients may present with a variety of symptoms, including fever, cough, chest pain, and weight loss, or more severe manifestations such as osteomyelitis or meningitis. Diagnosis typically involves clinical evaluation, imaging studies, and laboratory tests, including culture or serology. Treatment usually consists of antifungal medications such as itraconazole or amphotericin B, especially in immunocompromised patients who are at higher risk for severe disease. The management of blastomycosis can be complicated by the patient's immune status, making it crucial for healthcare providers to assess underlying conditions that may predispose patients to more severe infections.
Detailed clinical notes, laboratory results, and treatment plans.
Patients presenting with respiratory symptoms, fever, and weight loss.
Consideration of immunocompromised status and potential for atypical presentations.
Pulmonary function tests, imaging studies, and symptom assessments.
Patients with chronic cough and suspected pulmonary infections.
Differentiation from other pulmonary infections and thorough documentation of respiratory symptoms.
When a fungal culture is performed to confirm blastomycosis.
Document the reason for the culture and any relevant clinical findings.
Infectious disease specialists should ensure comprehensive documentation of the patient's history.
Common symptoms include fever, cough, chest pain, and weight loss. In disseminated cases, symptoms may vary based on the affected organs.
Diagnosis typically involves clinical evaluation, imaging studies, and laboratory tests, including culture or serology.
Treatment usually involves antifungal medications such as itraconazole or amphotericin B, especially in severe cases or in immunocompromised patients.
